Edarbi
Payments companies reported to CMS as associated with Edarbi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Edarbi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Edarbi
These are the largest totals companies reported as associated with Edarbi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ijaz Ahmad | Brooklyn, NY | Cardiovascular Disease | $414.77 |
| Robert Wrona | Orland Park, IL | Family Medicine | $353.28 |
| Ricardo Issa | New York, NY | Internal Medicine | $349.60 |
| Thomas Pearce | Gloucester, MA | Family Medicine | $325.56 |
| George Vanweelden | Wintersville, OH | Internal Medicine | $305.38 |
| Raul Heredia | Frankfort, KY | Cardiovascular Disease | $301.14 |
| Joseph Lamantia | Indiana, PA | Family Medicine | $291.56 |
| Elizabeth Zinni | Canfield, OH | Family | $247.07 |
| Louis White | Birmingham, MI | Family Medicine | $241.83 |
| Maxwell White | Birmingham, MI | Family Medicine | $241.83 |
Prescribed Edarbi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.